Alcresta
Massachusetts, US · 3 known investors
Alcresta Therapeutics develops enzyme-based therapeutic products to address nutritional care for enterally fed patients living with rare diseases. The company is based in Massachusetts and focuses on delivering novel enzymatic solutions within the biotechnology and pharmaceutical sector.
BiotechHealthtechMedical Devices
Founders & leadership
DO
Daniel OrlandoChief Executive Officer
Investors · 3
In the news
- UPDATED: Alcresta raises $49M for digestive enzyme launch | Fierce Biotechfiercebiotech.com · 2016
- Alcresta Infused With $10M Series B To Get First Product To Marketinsights.citeline.com · 2013
- Newton firm raises $10m for calorie-loading product - The Boston Globebostonglobe.com · 2013
- Alcresta Raises $10M in Series A Financing - FinSMEsfinsmes.com · 2012
- Alcresta Therapeutics - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.com